Particles for Humanity is a brand committed to transforming medical technologies developed in academic labs into practical solutions that meet the healthcare needs of people in developing countries. They specialize in creating breakthrough technologies that are specifically designed for low-income settings, where access to affordable medical technology is crucial. With years of experience and expertise, Particles for Humanity is able to successfully transition early-stage inventions into products that address health challenges in low and middle-income countries.

Their funding is provided by renowned organizations such as The Bill & Melinda Gates Foundation, King Philanthropies, and The Mulago Foundation. At Particles for Humanity, they understand the urgency to bring innovative and affordable products to billions of people suffering from preventable diseases. One of their key focuses is reducing vitamin A deficiency, which is a significant health threat for millions of children and pregnant mothers.

Their microencapsulation technology allows them to integrate vitamin A into dried foods, enabling its delivery to millions of people. Particles for Humanity follows a rigorous product development process aligned with the UN Sustainable Development Goals. They prioritize minimizing costs, incorporating feedback from end users, and collaborating with research firms to ensure their products have the maximum impact.

They also focus on partnering with existing manufacturing and distribution infrastructure to ensure efficient delivery. With their dedication to creating practical solutions for global health challenges, Particles for Humanity is at the forefront of revolutionizing healthcare accessibility in low-income settings